We thank our Corporate Partners for their kind support.
Premium Partners 2024
Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. Since 2019, Chiesi is the world’s largest biopharmaceutical group to be certified B Corp, meaning that its sustainability efforts are measured and assessed by the most ambitious global standards. The company aims at becoming net-zero by 2035. With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 30 countries, and counts more than 6,000 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.
The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.
By sharing neutral science-based information and education for healthcare professionals, the Institute fosters “Science for Better Nutrition” to contribute to the enhancement of the quality of people’s lives all over the world.
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Silver Partners 2024
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
At Johnson & Johnson, we believe health is everything.
Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured.
Where treatments are smarter and less invasive.
And solutions are personal.
Inspired by patients, we take health personally, because health is personal.
We innovate with purpose to lead where medicine is going.
Prolacta Bioscience® Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk-based nutritional products that are changing the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide spectrum of human diseases, including applications for infants requiring surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for the screening and testing of donor milk. Prolacta is a global company with headquarters in Duarte, California.
Bronze Partner 2024
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services and data analytics to make clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing connected and compassionate care, while simplifying the patient’s journey across the care pathway. Together, we’re creating a world where healthcare has no limits. Learn more at www.gehealthcare.com
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Silke Mader, for further information.
Platinum Partners 2023
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Premium Partners 2023
Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. Since 2019, Chiesi is the world’s largest biopharmaceutical group to be certified B Corp, meaning that its sustainability efforts are measured and assessed by the most ambitious global standards. The company aims at becoming net-zero by 2035. With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 30 countries, and counts more than 6,000 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.
At Johnson & Johnson, we believe health is everything.
Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured.
Where treatments are smarter and less invasive.
And solutions are personal.
Inspired by patients, we take health personally, because health is personal.
We innovate with purpose to lead where medicine is going.
The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.
By sharing neutral science-based information and education for healthcare professionals, the Institute fosters “Science for Better Nutrition” to contribute to the enhancement of the quality of people’s lives all over the world.
Prolacta Bioscience® Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk-based nutritional products that are changing the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide spectrum of human diseases, including applications for infants requiring surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for the screening and testing of donor milk. Prolacta is a global company with headquarters in Duarte, California.
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Silver Partners 2023
Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services and data analytics to make clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing connected and compassionate care, while simplifying the patient’s journey across the care pathway. Together, we’re creating a world where healthcare has no limits. Learn more at www.gehealthcare.com
Bronze Partners 2023
The safe delivery of the next generation is a significant responsibility for caregivers around the world. Because every pregnancy and birth is one of a kind, and each action you take can have a lasting impact on the course of a new life. Philips is committed to working with you to provide the best care possible – from the time a woman hears the joyful news she’s about to be a mom, through pregnancy, labor and delivery, postpartum, and on to the transition home. For more than 50 years, we have shared your passion in caring for mothers, babies, and their families. As a global team of people with firsthand experience in delivering the next generation, we understand that addressing immediate concerns is just as critical as providing long-term wellbeing. Our innovative, evidence-based solutions are designed to support a baby’s development while helping newborns bond with parents and family and get off to a healthy start.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
Platinum Partners 2022
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.
With over 100 years of experience and leadership in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps healthcare providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.
Premium Partners 2022
Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
At Johnson & Johnson, we believe health is everything.
Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured.
Where treatments are smarter and less invasive.
And solutions are personal.
Inspired by patients, we take health personally, because health is personal.
We innovate with purpose to lead where medicine is going.
The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.
By sharing neutral science-based information and education for healthcare professionals, the Institute fosters “Science for Better Nutrition” to contribute to the enhancement of the quality of people’s lives all over the world.
Prolacta Bioscience® Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk-based nutritional products that are changing the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide spectrum of human diseases, including applications for infants requiring surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for the screening and testing of donor milk. Prolacta is a global company with headquarters in Duarte, California.
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Silver Partners 2022
Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. Since 2019, Chiesi is the world’s largest biopharmaceutical group to be certified B Corp, meaning that its sustainability efforts are measured and assessed by the most ambitious global standards. The company aims at becoming net-zero by 2035. With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 30 countries, and counts more than 6,000 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.
The safe delivery of the next generation is a significant responsibility for caregivers around the world. Because every pregnancy and birth is one of a kind, and each action you take can have a lasting impact on the course of a new life. Philips is committed to working with you to provide the best care possible – from the time a woman hears the joyful news she’s about to be a mom, through pregnancy, labor and delivery, postpartum, and on to the transition home. For more than 50 years, we have shared your passion in caring for mothers, babies, and their families. As a global team of people with firsthand experience in delivering the next generation, we understand that addressing immediate concerns is just as critical as providing long-term wellbeing. Our innovative, evidence-based solutions are designed to support a baby’s development while helping newborns bond with parents and family and get off to a healthy start.
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
Platinum Partners 2021
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.
With over 100 years of experience and leadership in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps healthcare providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.
Premium Partners 2021
Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.
By sharing neutral science-based information and education for healthcare professionals, the Institute fosters “Science for Better Nutrition” to contribute to the enhancement of the quality of people’s lives all over the world.
Prolacta Bioscience® Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk-based nutritional products that are changing the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide spectrum of human diseases, including applications for infants requiring surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for the screening and testing of donor milk. Prolacta is a global company with headquarters in Duarte, California.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
Sanofi Pasteur, Sanofi’s Global Vaccines Business Unit, is a world leader in human vaccines. Together, we believe in a world in which no one suffers or dies from a vaccine-preventable disease.
Silver Partners 2021
The safe delivery of the next generation is a significant responsibility for caregivers around the world. Because every pregnancy and birth is one of a kind, and each action you take can have a lasting impact on the course of a new life. Philips is committed to working with you to provide the best care possible – from the time a woman hears the joyful news she’s about to be a mom, through pregnancy, labor and delivery, postpartum, and on to the transition home. For more than 50 years, we have shared your passion in caring for mothers, babies, and their families. As a global team of people with firsthand experience in delivering the next generation, we understand that addressing immediate concerns is just as critical as providing long-term wellbeing. Our innovative, evidence-based solutions are designed to support a baby’s development while helping newborns bond with parents and family and get off to a healthy start.
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 237-year history in Japan.
Bronze Partners 2021
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
We strive to change the practice of medicine. We aspire to approach things differently—to make discoveries that take medicine in new directions. We look to tomorrow to inspire us today. Never satisfied with the status quo, we imagine what’s next.
We are passionate about what we do and the impact we have on patients and societies.
We are Novartis, and we are reimagining medicine.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
Platinum Partners 2020
GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.
With over 100 years of experience and leadership in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps healthcare providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.
Premium Partners 2020
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.
By sharing neutral science-based information and education for healthcare professionals, the Institute fosters “Science for Better Nutrition” to contribute to the enhancement of the quality of people’s lives all over the world.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
Sanofi Pasteur, Sanofi’s Global Vaccines Business Unit, is a world leader in human vaccines. Together, we believe in a world in which no one suffers or dies from a vaccine-preventable disease.
Premium Project Partners 2020
Prolacta Bioscience® Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk-based nutritional products that are changing the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide spectrum of human diseases, including applications for infants requiring surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for the screening and testing of donor milk. Prolacta is a global company with headquarters in Duarte, California.
Silver Partners 2020
The safe delivery of the next generation is a significant responsibility for caregivers around the world. Because every pregnancy and birth is one of a kind, and each action you take can have a lasting impact on the course of a new life. Philips is committed to working with you to provide the best care possible – from the time a woman hears the joyful news she’s about to be a mom, through pregnancy, labor and delivery, postpartum, and on to the transition home. For more than 50 years, we have shared your passion in caring for mothers, babies, and their families. As a global team of people with firsthand experience in delivering the next generation, we understand that addressing immediate concerns is just as critical as providing long-term wellbeing. Our innovative, evidence-based solutions are designed to support a baby’s development while helping newborns bond with parents and family and get off to a healthy start.
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 237-year history in Japan.
Bronze Partners 2020
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
We strive to change the practice of medicine. We aspire to approach things differently—to make discoveries that take medicine in new directions. We look to tomorrow to inspire us today. Never satisfied with the status quo, we imagine what’s next.
We are passionate about what we do and the impact we have on patients and societies.
We are Novartis, and we are reimagining medicine.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
Platinum Partner 2019
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
Premium Partners 2019
Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.
By sharing neutral science-based information and education for healthcare professionals, the Institute fosters “Science for Better Nutrition” to contribute to the enhancement of the quality of people’s lives all over the world.
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
We strive to change the practice of medicine. We aspire to approach things differently—to make discoveries that take medicine in new directions. We look to tomorrow to inspire us today. Never satisfied with the status quo, we imagine what’s next.
We are passionate about what we do and the impact we have on patients and societies.
We are Novartis, and we are reimagining medicine.
For over 30 years, Philips AVENT has been working with a global network of trusted partners including scientific experts, research institutes, healthcare professionals and parents. Philips AVENT is committed to bring the latest research in the fields of breastfeeding, infant feeding and development, to healthcare professionals and parents; translating key concepts into innovatively designed and evidence-based products and services. The first 1,000 days are critical to setting the foundation for long-term health and this is when Philips AVENT supports parents to shape the healthy development of their child.
Philips AVENT understands that breast milk is the best nutrition for babies. We are passionate about helping more woman to give breast milk to their babies for longer, through innovation and research.
We believe it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 237-year history in Japan.
Premium Project Partners 2019
Prolacta Bioscience® Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk-based nutritional products that are changing the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide spectrum of human diseases, including applications for infants requiring surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for the screening and testing of donor milk. Prolacta is a global company with headquarters in Duarte, California.
Silver Partners 2019
Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.
Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam.
Bronze Partners 2019
GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.
With over 100 years of experience and leadership in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps healthcare providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.
Visit the website www.gehealthcare.com for more information.
Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.
Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.
Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.
Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
Platinum Partner 2018
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
Premium Partners 2018
Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
We strive to change the practice of medicine. We aspire to approach things differently—to make discoveries that take medicine in new directions. We look to tomorrow to inspire us today. Never satisfied with the status quo, we imagine what’s next. We are passionate about what we do and the impact we have on patients and societies. We are Novartis, the impact we have on patients and societies and we are reimagining medicine.
For over 30 years, Philips AVENT has been working with a global network of trusted partners including scientific experts, research institutes, healthcare professionals and parents. Philips AVENT is committed to bring the latest research in the fields of breastfeeding, infant feeding and development, to healthcare professionals and parents; translating key concepts into innovatively designed and evidence-based products and services. The first 1,000 days are critical to setting the foundation for long-term health and this is when Philips AVENT supports parents to shape the healthy development of their child.
Philips AVENT understands that breast milk is the best nutrition for babies. We are passionate about helping more woman to give breast milk to their babies for longer, through innovation and research.
We believe it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.
Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
Silver Partners 2018
Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.
Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam.
Bronze Partner 2018
Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.
Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.
Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.
Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2017
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
Baxter has been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.
Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
For over 30 years, Philips AVENT has been working with a global network of trusted partners including scientific experts, research institutes, healthcare professionals and parents. Philips AVENT is committed to bring the latest research in the fields of breastfeeding, infant feeding and development, to healthcare professionals and parents; translating key concepts into innovatively designed and evidence-based products and services.
The first 1,000 days are critical to setting the foundation for long-term health and this is when Philips AVENT supports parents to shape the healthy development of their child.
Philips AVENT understands that breast milk is the best nutrition for babies. We are passionate about helping more woman to give breast milk to their babies for longer, through innovation and research. We believe it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.
Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
Silver Partner 2017
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam.
Bronze Partner 2017
Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.
Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.
Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.
Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2016
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.
Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
For over 30 years, Philips AVENT has been working with a global network of trusted partners including scientific experts, research institutes, healthcare professionals and parents. Philips AVENT is committed to bring the latest research in the fields of breastfeeding, infant feeding and development, to healthcare professionals and parents; translating key concepts into innovatively designed and evidence-based products and services.
The first 1,000 days are critical to setting the foundation for long-term health and this is when Philips AVENT supports parents to shape the healthy development of their child.
Philips AVENT understands that breast milk is the best nutrition for babies. We are passionate about helping more woman to give breast milk to their babies for longer, through innovation and research. We believe it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.
Silver Partner 2016
<span id=”Prolacta”/>
Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
Bronze Partner 2016
Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.
Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.
Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.
Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2015
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
For over 30 years, Philips AVENT has been working with a global network of trusted partners including scientific experts, research institutes, healthcare professionals and parents. Philips AVENT is committed to bring the latest research in the fields of breastfeeding, infant feeding and development, to healthcare professionals and parents; translating key concepts into innovatively designed and evidence-based products and services.
The first 1,000 days are critical to setting the foundation for long-term health and this is when Philips AVENT supports parents to shape the healthy development of their child.
Philips AVENT understands that breast milk is the best nutrition for babies. We are passionate about helping more woman to give breast milk to their babies for longer, through innovation and research. We believe it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.
Premium Project Partner 2015
Dräger is an international leader in the fields of medical and safety technology.
The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.
The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.
Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.
Silver Partner 2015
Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
Bronze Partner 2015
Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.
Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.
Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.
Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2014
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
For over 30 years, Philips AVENT has been working with a global network of trusted partners including scientific experts, research institutes, healthcare professionals and parents. Philips AVENT is committed to bring the latest research in the fields of breastfeeding, infant feeding and development, to healthcare professionals and parents; translating key concepts into innovatively designed and evidence-based products and services.
The first 1,000 days are critical to setting the foundation for long-term health and this is when Philips AVENT supports parents to shape the healthy development of their child.
Philips AVENT understands that breast milk is the best nutrition for babies. We are passionate about helping more woman to give breast milk to their babies for longer, through innovation and research. We believe it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.
Premium Project Partner 2014
Dräger is an international leader in the fields of medical and safety technology.
The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.
The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.
Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.
Silver Partner 2014
Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
Bronze Partner 2014
Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2013
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
PerkinElmer is a specialist in the identification of disorders during pregnancy and in the first days of a baby’s life. Our focus is on just those diseases where early detection can allow effective treatment. Over the past 25 years PerkinElmer screening tests have been used to check many millions of pregnancies or newborn babies, and it is estimated that currently some 50 babies per day, somewhere in the world are able to move forward to a healthy childhood because their disorder was detected in time by a PerkinElmer test.
During pregnancy, we have pioneered new screening methods for pre-eclampsia which will identify high risk pregnancies already during the first trimester. There is growing evidence that early treatment of the high risk cases can delay or prevent the development of the disease.
Premium Project Partner 2013
Dräger is an international leader in the fields of medical and safety technology.
The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.
The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.
Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.
Bronze Partner 2013
Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2012
Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
PerkinElmer is a specialist in the identification of disorders during pregnancy and in the first days of a baby’s life. Our focus is on just those diseases where early detection can allow effective treatment. Over the past 25 years PerkinElmer screening tests have been used to check many millions of pregnancies or newborn babies, and it is estimated that currently some 50 babies per day, somewhere in the world are able to move forward to a healthy childhood because their disorder was detected in time by a PerkinElmer test.
During pregnancy, we have pioneered new screening methods for pre-eclampsia which will identify high risk pregnancies already during the first trimester. There is growing evidence that early treatment of the high risk cases can delay or prevent the development of the disease.
Premium Project Partner 2012
Dräger is an international leader in the fields of medical and safety technology.
The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.
The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.
Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.
Bronze Partner 2012
Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2011
Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
Premium Project Partner 2011
Dräger is an international leader in the fields of medical and safety technology.
The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.
The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.
Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.
Bronze Partner 2011
Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2010
Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2009
Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.
We thank all our partners for their kind support.
Premium Partners 2008
Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
How to become a partner
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.